Véronique RIBAN,Marc VERLEYE,Marie-Emmanuelle LE GUERN
申请号：
US16617720
公开号：
US20200179335A1
申请日:
2018.05.30
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to a compound of the following formula (I):or a pharmaceutically acceptable salt, hydrate or solvate thereof,for use in the prevention or treatment of a disease associated with a dysregulation of the mTOR pathway in an individual.
